Validation approaches for computational drug repurposing: a review.
作者信息
Pillai Malvika, Wu Di
机构信息
Stanford University, Stanford, CA.
University of North Carolina, Chapel Hill, NC.
出版信息
AMIA Annu Symp Proc. 2024 Jan 11;2023:559-568. eCollection 2023.
Abstract
摘要
相似文献
1
Validation approaches for computational drug repurposing: a review.
AMIA Annu Symp Proc. 2024 Jan 11;2023:559-568. eCollection 2023.
2
Web-based Tools for Drug Repurposing: Successful Examples of Collaborative Research.
Curr Med Chem. 2021;28(1):181-195. doi: 10.2174/0929867327666200128111925.
3
Evaluating the performance of drug-repurposing technologies.
Drug Discov Today. 2022 Jan;27(1):49-64. doi: 10.1016/j.drudis.2021.08.002. Epub 2021 Aug 13.
4
Network-Based Drug Repositioning: Approaches, Resources, and Research Directions.
Methods Mol Biol. 2019;1903:97-113. doi: 10.1007/978-1-4939-8955-3_6.
5
In silico drug repositioning: what we need to know.
Drug Discov Today. 2013 Feb;18(3-4):110-5. doi: 10.1016/j.drudis.2012.08.005. Epub 2012 Aug 28.
6
A survey of current trends in computational drug repositioning.
Brief Bioinform. 2016 Jan;17(1):2-12. doi: 10.1093/bib/bbv020. Epub 2015 Mar 31.
7
A review of validation strategies for computational drug repositioning.
Brief Bioinform. 2018 Jan 1;19(1):174-177. doi: 10.1093/bib/bbw110.
8
A systematic review of computational approaches to understand cancer biology for informed drug repurposing.
J Biomed Inform. 2023 Jun;142:104373. doi: 10.1016/j.jbi.2023.104373. Epub 2023 Apr 27.
9
An Analytical Review of Computational Drug Repurposing.
IEEE/ACM Trans Comput Biol Bioinform. 2021 Mar-Apr;18(2):472-488. doi: 10.1109/TCBB.2019.2933825. Epub 2021 Apr 6.
10
Computational biology: future challenges for the patenting of repurposed drugs.
Pharm Pat Anal. 2017 Sep;6(5):201-203. doi: 10.4155/ppa-2017-0018. Epub 2017 Aug 18.
引用本文的文献
1
Deciphering anti-colorectal cancer potential of Avicennia alba bioactives via network pharmacology and in vitro validation.
Sci Rep. 2025 Jul 31;15(1):27976. doi: 10.1038/s41598-025-12500-x.
2
Repositioning FDA-Approved Sulfonamide-Based Drugs as Potential Carbonic Anhydrase Inhibitors in : Virtual Screening and In Vitro Studies.
Pharmaceuticals (Basel). 2025 May 1;18(5):669. doi: 10.3390/ph18050669.
本文引用的文献
1
BiRWDDA: A Novel Drug Repositioning Method Based on Multisimilarity Fusion.
J Comput Biol. 2019 Nov;26(11):1230-1242. doi: 10.1089/cmb.2019.0063. Epub 2019 May 29.
2
Computational drug repurposing for inflammatory bowel disease using genetic information.
Comput Struct Biotechnol J. 2019 Jan 7;17:127-135. doi: 10.1016/j.csbj.2019.01.001. eCollection 2019.
3
Repurposing of Approved Cardiovascular Drugs against Ischemic Cerebrovascular Disease by Disease-Disease Associated Network-Assisted Prediction.
Chem Pharm Bull (Tokyo). 2019 Jan 1;67(1):32-40. doi: 10.1248/cpb.c18-00634. Epub 2018 Nov 8.
4
New approach for understanding genome variations in KEGG.
Nucleic Acids Res. 2019 Jan 8;47(D1):D590-D595. doi: 10.1093/nar/gky962.
5
Drug repurposing: progress, challenges and recommendations.
Nat Rev Drug Discov. 2019 Jan;18(1):41-58. doi: 10.1038/nrd.2018.168. Epub 2018 Oct 12.
6
The Comparative Toxicogenomics Database: update 2019.
Nucleic Acids Res. 2019 Jan 8;47(D1):D948-D954. doi: 10.1093/nar/gky868.
7
Network-based approach to prediction and population-based validation of in silico drug repurposing.
Nat Commun. 2018 Jul 12;9(1):2691. doi: 10.1038/s41467-018-05116-5.
8
Predicting drug-disease associations and their therapeutic function based on the drug-disease association bipartite network.
Methods. 2018 Aug 1;145:51-59. doi: 10.1016/j.ymeth.2018.06.001. Epub 2018 Jun 4.
9
Systematic Identification of Druggable Epithelial-Stromal Crosstalk Signaling Networks in Ovarian Cancer.
J Natl Cancer Inst. 2019 Mar 1;111(3):272-282. doi: 10.1093/jnci/djy097.
10
Drug repositioning for prostate cancer: using a data-driven approach to gain new insights.
AMIA Annu Symp Proc. 2018 Apr 16;2017:1724-1733. eCollection 2017.
Zotero 插件